Aerie Pharmaceuticals, Inc.

/Aerie Pharmaceuticals, Inc.

They are an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma or ocular hypertension and other diseases of the eye.

Symbol

Last Closing Price
$61.00

Shares
1,300,000

Effective Date
January 24, 2018

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange